![Mark Oki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/08/2026
Mark K.
Oki is currently Chief Financial Officer at Neos Therapeutics, Inc. and Chief Financial Officer at Achieve Life Sciences, Inc. Formerly, Mr. Oki was Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. from 2022 to 2024; Chief Financial & Accounting Officer at VIVUS, Inc. from 2015 to 2019; CFO, Secretary & Senior VP-Finance at Alexza Pharmaceuticals, Inc. in 2015; Controller at Pharmacyclics LLC in 2006; and Assistant Controller at Incyte Corp.
from 1998 to 2001.
Education includes an undergraduate degree from San Jose State University conferred in 1991.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/01/2026 | 127.940 ( 0,12 % ) | 1 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Director Financiero/CFO | - |
| ACHIEVE LIFE SCIENCES, INC. | Director Financiero/CFO | 05/12/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director Financiero/CFO | 11/11/2024 |
| ALEXZA PHARMACEUTICALS, INC. | Director Financiero/CFO | 16/10/2015 |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 01/04/2006 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/01/2001 |
| VIVUS, INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
